UK Covid-19 Inquiry: Vaccines and therapeutics (Module 4) Report
The UK Covid-19 Inquiry’s fourth report considers the development and rollout of vaccines across the UK and treatment of Covid-19 using existing and new medications.
Documents
Details
The Covid-19 Inquiry is an independent public inquiry established to examine the UK’s response to and impact of the Covid-19 pandemic, and to learn lessons for the future. The Inquiry conducted its public hearings for each module between June 2023 and March 2026 and began publishing reports containing findings and recommendations from July 2024.
Module 4 examined the development and rollout of vaccines across the UK and treatment of Covid-19 using existing and new medications.
- Module 4 Report - Vaccines and therapeutics. Available in English and machine-translated to all other languages on the Inquiry’s website.
- Module 4 Report - ‘In-Brief’ summary - Vaccines and therapeutics. The ‘In Brief’ summary is available in English, Welsh, English Easy Read, a video animation and audio only format. It is also machine-translated to all other languages available on the Inquiry’s website.
Reports relating to the Inquiry’s other Modules will be published until 2027 and details of these can be found here: Inquiry Module Reports. A full list of the Inquiry’s modules and the topics that have been investigated can be found in the Structure of the Inquiry.
For further information, see the Inquiry’s Terms of Reference.